A little stress is good:: IFN-γ, demyelination, and multiple sclerosis

被引:46
|
作者
Lees, Jason R.
Cross, Anne H.
机构
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2007年 / 117卷 / 02期
关键词
D O I
10.1172/JCI31254
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The exact role(s) of the cytokine IFN-gamma in the demyelinating disease multiple sclerosis remain controversial, with evidence suggesting both detrimental and protective effects of the cytokine in MS and MS models such as EAE. The study by Lin and coworkers in this issue of the JCI produces evidence that protective effects of IFN-gamma on mature oligodendrocytes during EAE induction are mediated via activation of the pancreatic ER kinase (PERK), resulting in induction of the endoplasmic reticular stress response pathway (see the related article beginning on page 448). Modulation of this stress pathway has what we believe to be novel therapeutic potential for MS.
引用
收藏
页码:297 / 299
页数:3
相关论文
共 50 条
  • [31] Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
    Rolla, Simona
    Bardina, Valentina
    De Mercanti, Stefania
    Quaglino, Pietro
    De Palma, Raffaele
    Gned, Dario
    Brusa, Davide
    Durelli, Luca
    Novelli, Francesco
    Clerico, Marinella
    JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 96 (06) : 1155 - 1164
  • [32] A randomized comparative study of antibody development to IFN-β1A and IFN-β1B in patients with multiple sclerosis
    Ross, C
    Svenson, M
    Koch-Henriksen, N
    Soelberg-Sorensen, P
    Skovgaard, GL
    Bendtzen, K
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 502 - 502
  • [33] Dendritic cells (DC) are potent producers of IFN-γ in multiple sclerosis (MS)
    Link, H
    Kouwenhoven, M
    Xiao, BG
    Xu, LY
    Fredrickson, S
    Huang, YM
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 448A - 448A
  • [35] Neutralizing and binding anti-interferon-β (IFN-β) antibodies.: A comparison between IFN-β-1a and IFN-β-1b treatment in multiple sclerosis
    Kivisäkk, P
    Alm, GV
    Fredrikson, S
    Link, H
    EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 (01) : 27 - 34
  • [36] Neurodegeneration and demyelination in multiple sclerosis
    Garton, Thomas
    Gadani, Sachin P.
    Gill, Alexander J.
    Calabresi, Peter A.
    NEURON, 2024, 112 (19) : 3231 - 3251
  • [37] Neutralizing and binding antibodies to IFN-β:: Relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-β preparations
    Scagnolari, C
    Bellomi, F
    Turriziani, O
    Bagnato, F
    Tomassini, V
    Lavolpe, V
    Ruggieri, M
    Bruschi, F
    Meucci, G
    Dicuonzo, G
    Antonelli, G
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (02): : 207 - 213
  • [38] Demyelination is not always multiple sclerosis
    Ventura, N.
    Lopes, F.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1833 - 1834
  • [39] Pseudocystic demyelination in multiple sclerosis
    Hardy, Todd A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (10) : 1344 - 1345
  • [40] Antibodies and demyelination in multiple sclerosis
    不详
    NEUROSCIENTIST, 2000, 6 (02): : 69 - 69